FAQs: How to manage a CT - CTIS Training Programme - Module 05
Submitted by Anonymous (not verified) on 14 August 2024 - 16:48
FAQs: How to manage a CT - CTIS Training Programme - Module 05
HMPC meeting report on European Union herbal monographs, guidelines and other activities - 27-29 May 2024
Submitted by Anonymous (not verified) on 14 August 2024 - 16:39
HMPC meeting report on European Union herbal monographs, guidelines and other activities - 27-29 May 2024
Download medicine data
Submitted by Anonymous (not verified) on 14 August 2024 - 16:37
Download medicine data
Questions and answers on the impact of mutual recognition agreement between the European Union and the United States as of 7 August 2024
Submitted by Anonymous (not verified) on 14 August 2024 - 15:51
Questions and answers on the impact of mutual recognition agreement between the European Union and the United States as of 7 August 2024
Questions and answers relating to Grant Procedure no. EMA/GRANT/2024/02/IA - Medicines regulatory systems strengthening in Sub-Saharan Africa
Submitted by Anonymous (not verified) on 14 August 2024 - 15:30
Questions and answers relating to Grant Procedure no. EMA/GRANT/2024/02/IA - Medicines regulatory systems strengthening in Sub-Saharan Africa
Scientific advice and protocol assistance adopted during the CHMP meeting 22-25 July 2024
Submitted by Anonymous (not verified) on 14 August 2024 - 13:36
Scientific advice and protocol assistance adopted during the CHMP meeting 22-25 July 2024
Human medicines European public assessment report (EPAR): Lymphoseek, tilmanocept, Date of authorisation: 19/11/2014, Revision: 8, Status: Withdrawn (authorisation)
Submitted by Anonymous (not verified) on 14 August 2024 - 13:19
Human medicines European public assessment report (EPAR): Lymphoseek, tilmanocept, Date of authorisation: 19/11/2014, Revision: 8, Status: Withdrawn (authorisation)
Glatiramer acetate
Submitted by Anonymous (not verified) on 14 August 2024 - 9:13
Glatiramer acetate
Human medicines European public assessment report (EPAR): Intelence, etravirine, Date of authorisation: 28/08/2008, Revision: 31, Status: Authorised
Submitted by Anonymous (not verified) on 13 August 2024 - 15:40
Human medicines European public assessment report (EPAR): Intelence, etravirine, Date of authorisation: 28/08/2008, Revision: 31, Status: Authorised
European Union example instances - E2B(R3) testing files
Submitted by Anonymous (not verified) on 13 August 2024 - 15:09
European Union example instances - E2B(R3) testing files